Enveda Biosciences

Enveda Biosciences combines AI and advanced mass spectrometry to decode the complex chemistry of natural products — the compounds found in plants, microbes, and other organisms — to discover novel therapeutics. The company is mapping 'dark chemical matter,' the vast majority of natural molecules whose structures and activities remain unknown, creating a fundamentally new source of drug candidates.

$360M+

Total raised

Combines machine learning with high-resolution mass spectrometry to map the structures and bioactivities of previously unknown natural product molecules. This approach unlocks nature's 'dark chemical matter' — billions of years of evolutionary chemical optimization — as a source of novel therapeutics.